Skip to main content

Advertisement

SpringerLink
Log in

Very Rare Recurrence Site of Hepatocellular Carcinoma After Living Donor Liver Transplantation: Subcutaneous Abdominal Drain Tract

  • Case Report
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Abbreviations

AFP:

Alpha fetoprotein

ALT:

Alanine amino transferase

ALP:

Alkaline phosphatase

AST:

Aspartate aminotransferase

BMI:

Body mass index

CNI:

Calcineurin inhibitor

GGT:

Gamma glutamyl transferase

GRWR:

Graft to recipient weight ratio

HBV:

Hepatitis B virus

HCC:

Hepatocellular carcinoma

LDLT:

Living donor liver transplantation

LT:

Liver transplantation

MMF:

Mycophenolate mofetil

mTORi:

Mammalian target of rapamycin inhibitor

NLR:

Neutrophil to lymphocyte ratio

PCR:

Polymerase chain reaction

PLR:

Platelet to lymphocyte ratio

POD:

Postoperative day

References

  1. Sapisochin G, Goldaracena N, Laurence JM, Dib M, Barbas A, Ghanekar A, et al. The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: a prospective validation study. Hepatology. 2016;64:2077–88. https://doi.org/10.1002/hep.28643.

  2. Ince V, Akbulut S, Otan E, et al. (2020) Liver transplantation for hepatocellular carcinoma: Malatya Experience and proposals for expanded criteria. J Gastrointest Cancer (in press): https://doi.org/10.1007/s12029-020-00424-w.

  3. Foerster F, Hoppe-Lotichius M, Vollmar J, Marquardt JU, Weinmann A, Wörns MA, et al. Long-term observation of hepatocellular carcinoma recurrence after liver transplantation at a European transplantation centre. United European Gastroenterol J. 2019;7:838–49.

  4. Koffi E, Moutardier V, Sauvanet A, Noun R, Fléjou JF, Belghiti J. Wound recurrence after resection of hepatocellular carcinoma. Liver Transpl Surg. 1996;2:301–3.

    Article  CAS  Google Scholar 

  5. Barrett M, Nathan H, Vankayala H, Bieliauskas SL, Viglianti BL, Frankel TL. Recurrence of hepatocellular carcinoma at surgical incision site: case series and review of literature. Ann R Coll Surg Engl. 2017;99:e177–19.

    Article  CAS  Google Scholar 

  6. Cholongitas E, Mamou C, Rodríguez-Castro KI, Burra P. Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review. Transpl Int. 2014;27:1039–49.

    Article  CAS  Google Scholar 

  7. Ersan V, Ince V, Otan E, et al. Effect of mammalian target of rapamycin inhibitors on hepatocellular carcinoma recurrence in liver transplant patients: Malatya experience [abstract]. Transplantation. 2017;101(suppl 2S):380–1.

    Google Scholar 

  8. Geissler EK, Schnitzbauer AA, Zülke C, Lamby PE, Proneth A, Duvoux C, et al. Sirolimus use in liver transplant recipients with hepatocellular carcinoma: a randomized, multicenter, open-label phase 3 trial. Transplantation. 2016;100(1):116–25.

Download references

Author information

Authors and Affiliations

  1. Liver Transplantation Institute, Department of Surgery, Inonu University, 44315, Malatya, Turkey

    Zeki Ogut, Burak Kilci, Volkan Ince, Cemalettin Koc, Burak Isik & Sezai Yilmaz

Authors
  1. Zeki Ogut
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Burak Kilci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Volkan Ince
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cemalettin Koc
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Burak Isik
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sezai Yilmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Volkan Ince.

Ethics declarations

Conflict of Interest

The authors declare that there is no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ogut, Z., Kilci, B., Ince, V. et al. Very Rare Recurrence Site of Hepatocellular Carcinoma After Living Donor Liver Transplantation: Subcutaneous Abdominal Drain Tract. J Gastrointest Canc 52, 310–312 (2021). https://doi.org/10.1007/s12029-020-00429-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-020-00429-5

Search

Navigation